Verve Therapeutics
Price & Volume
Stats
See more| 52W Range | $4.90-$21.04 |
| Market Cap | $448.3M |
| Shares Short | 18M |
Financials
See more| Revenue (12 Mos) | $16M |
| Revenue Growth (YoY) | 305.6% |
| Gross Profit (12 Mos) | -$128.1M |
| Diluted EPS | -$2.87 |
News
See moreYahoo Finance • 6 months ago
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
Yahoo Finance • 7 months ago
12 Best Genomics Stocks To Buy Now
Yahoo Finance • 7 months ago
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
Yahoo Finance • 7 months ago
Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
About
| CEO | Dr. Sekar Kathiresan M.D. |
| CFO | Ms. Allison Dorval |
| Address | 201 Brookline Avenue, Cambridge, MA, United States, 02215 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Full-Time Employees | 255 |
